Aspirin constitutes important lifelong therapy for many patients with cardiovascular (CV) disease or significant CV risk factors. However, perioperative aspirin management (continuation versus temporary cessation) in patients undergoing noncardiac surgery is a common clinical conundrum that balances aspirinâs potential for decreasing thrombotic risk against possible increased perioperative blood loss. Dr. Neal Stuart Gerstein, Department of […]
Perioperative management of aspirin therapy
